Therapy‐related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy* (Q34227027)

31 July 2017

title

Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy (English)

1 reference

31 July 2017

Therapy‐related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy* (English)

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

15 December 2024

1 reference

acute promyelocytic leukemia

1 reference

3

Ayalew Tefferi

1 reference

31 July 2017

13

Mark R Litzow

1 reference

31 July 2017

6

Scott H. Kaufmann

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22023492

15 December 2024

author name string

Louis Letendre

2

1 reference

31 July 2017

Christopher Hook

5

1 reference

31 July 2017

Animesh Pardanani

8

1 reference

31 July 2017

Aref Al-Kali

12

1 reference

31 July 2017

Michelle A. Elliott

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22023492

15 December 2024

William J. Hogan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22023492

15 December 2024

Rajiv K. Pruthi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22023492

15 December 2024

Kebede H. Begna

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22023492

15 December 2024

Aneel A. Ashrani

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22023492

15 December 2024

Alexandra P. Wolanskyj

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:22023492

15 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=22023492

15 December 2024

publication date

17 November 2011

1 reference

full work available at URL

31 July 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111/j.1600-0609.2011.01727.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-0609.2011.01727.x

15 December 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

European Journal of Haematology

15 December 2024

published in

1 reference

31 July 2017

volume

88

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

237-243

1 reference

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

DNA topoisomerase II in therapy-related acute promyelocytic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Management of APL in developing countries: epidemiology, challenges and opportunities for international collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Outcome of therapy-related acute promyelocytic leukemia with or without arsenic trioxide as a component of frontline therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

PML-RARalpha is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Impact of additional chromosomal abnormalities in patients with acute promyelocytic leukemia: 10-year results of the Japan Adult Leukemia Study Group APL97 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Effective treatment of acute promyelocytic leukemia with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia

21 January 2018

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups

15 December 2024

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia

15 December 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0609.2011.01727.X

15 December 2024

Identifiers

1 reference

31 July 2017

1 reference